Back
Speaker illustration

Doctor Daniel Peter Andersson

Karolinska Institute, Stockholm (Sweden)

Presentations

Association between treatment with phosphodiesterase-5 inhibitors, versus alprostadil and survival in patients with coronary artery disease

Event: ESC Congress 2018

Topic: Cardiovascular Risk Assessment, Other

Session: Secondary prevention

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources